10
total announcements
531686.BO · 15 min delayed
Advik Laboratories Ltd
Advik Laboratories Ltd has published a newspaper notice regarding its 32nd Annual General Meeting (AGM), book closure, and remote e-voting information, as per SEBI regulations.
Advik Laboratories Ltd
Advik Laboratories Ltd, now known as MPS Pharmaa Ltd, has announced the recommendation of Ms. Anchal Goyal as an Independent Director and the re-appointment of M/s. Nemani Garg Agarwal & Co. as Statutory Auditors at its Board meeting held on September 2, 2026.
Advik Laboratories Ltd
Advik Laboratories Ltd (now MPS Pharmaa Ltd) has announced the appointment of M/s. Nemani Garg Agarwal & Co. as the Statutory Auditors of the Company, and the re-appointment of Ms. Anchal Goyal as an Independent Director for a term of 5 consecutive years.
Advik Laboratories Ltd
Advik Laboratories Ltd, now known as MPS Pharmaa Ltd, has announced the date and time of its 32nd Annual General Meeting (AGM) to be held on September 29, 2026, at its registered office. The company has also approved the appointment of Ms. Anchal Goyal as an Independent Director and the re-appointment of M/s. Nemani Garg Agarwal & Co. as Statutory Auditors.
Advik Laboratories Ltd
Advik Laboratories Ltd (now MPS Pharmaa Ltd) has announced the outcome of its board meeting, where it approved several key decisions, including the date and time of its 32nd Annual General Meeting, the appointment of an independent director, and the re-appointment of its statutory auditors.
Advik Laboratories Ltd
Advik Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 to consider and approve various matters, including the notice calling Annual General Meeting (AGM) for the Financial Year 2025-26.
Advik Laboratories Ltd
Advik Laboratories Ltd has submitted a newspaper publication regarding its unaudited financial results for the quarter ended 30th June, 2026, as per Regulation 47 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations, 2015.
Advik Laboratories Ltd
Advik Laboratories Ltd has submitted its unaudited financial results for the quarter ended June 30, 2026, showing a net loss of Rs. 23.80 crores. The company has applied for renewal of its drug manufacturing licenses and is exploring new business opportunities.
Advik Laboratories Ltd
Advik Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net loss of Rs. 23.80 crores. The company's revenue from operations was Rs. 3.56 crores, and its expenses were Rs. 23.80 crores. The company has applied for renewal of its Drug Manufacturing Licences and is exploring market and business opportunities to restart its operations.
Advik Laboratories Ltd
Advik Laboratories Ltd has scheduled a board meeting on 13th August 2026 to consider and approve the un-audited financial results for the quarter ended 30th June 2026.